Effects of mind-body exercise Baduanjin on cognition in community-dwelling older people with mild cognitive impairment: A randomized controlled trial

Author: Rui Xia1, Mingyue Wan2, Huiying Lin2, Yu Ye2, Shangjie Chen1, Guohua Zheng3
1 The Second Affiliated Hospital of Shenzhen University, Shenzhen, People's Republic of China.
2 College of Rehabilitation Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, People's Republic of China.
3 College of Nursing and Health Management, Shanghai University of Medicine & Health Sciences, Shanghai, People's Republic of China.
Conference/Journal: Neuropsychol Rehabil
Date published: 2022 Jul 15
Other: Special Notes: doi: 10.1080/09602011.2022.2099909. , Word Count: 203

To determine the effect of a 6-month traditional Chinese mind-body Baduanjin exercise intervention on cognitive ability in older people with Mild cognitive impairment (MCI).

A total of 135 community-dwelling seniors with MCI were randomized into either the Baduanjin group (BDJ), the brisk walking group (BWK) or the usual physical activity control group (UPA). Cognitive ability was assessed at baseline, 2, 4 and 6 months post-intervention, and 3 months after the intervention ended.

After 6 months of intervention, the MoCA score of the BDJ group was significantly higher than that of the UPA group (P < 0.05), The Go/No-go correct numbers of the BDJ group and BWK group were significantly higher than those of the UPA group (P < 0.05). There was no statistical difference in other outcomes, or there were only a tiny effect size. Three months after the intervention, there was no significant difference between the primary and secondary outcomes(P > 0.05).

The 6-month period of Baduanjin training has positive benefits on global cognitive function and attention function in community-dwelling elderly individuals with MCI. The effect seems to have been transient and needs to be confirmed by additional studies.

Keywords: Baduanjin; Traditional Chinese mind–body exercise; cognition; mild cognitive impairment; randomized controlled trial.

PMID: 35838817 DOI: 10.1080/09602011.2022.2099909